MongoDB Forecast, price target & analysts
MongoDB Target price 2025 - Analyst rating & recommendation
MongoDB Classifications & Recommendation:
MongoDB Price Target
| Target Price | $295.67 |
| Price | $198.66 |
| Potential | 48.83% |
| Number of Estimates | 27 |
| 27 Analysts have issued a price target MongoDB 2026 . The average MongoDB target price is $295.67. This is 48.83% higher than the current stock price. The highest price target is $350.00 76.18% , the lowest is $215.00 8.23% . | |
| A rating was issued by 35 analysts: 25 Analysts recommend MongoDB to buy, 9 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the MongoDB stock has an average upside potential 2026 of 48.83% . Most analysts recommend the MongoDB stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2030
31 Analysts have issued a sales forecast MongoDB 2026 . The average MongoDB sales estimate is $2.3b . This is 13.57% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $2.4b 17.82% , the lowest is $2.3b 12.54% .
This results in the following potential growth metrics:
Revenue Estimates
| 2025 | $2.0b | 19.22% |
|---|---|---|
| 2026 | $2.3b | 13.57% |
| 2027 | $2.7b | 16.56% |
| 2028 | $3.2b | 18.66% |
| 2029 | $3.7b | 18.33% |
| 2030 | $4.4b | 16.93% |
11 Analysts have issued an MongoDB EBITDA forecast 2026. The average MongoDB EBITDA estimate is $234m . This is 224.01% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $271m 243.54% , the lowest is $222m 217.46% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2025 | $-189m | 6.29% |
|---|---|---|
| 2026 | $234m | 223.92% |
| 2027 | $338m | 44.25% |
| 2028 | $558m | 64.99% |
EBITDA Margin
| 2025 | -9.43% | 21.40% |
|---|---|---|
| 2026 | 10.29% | 209.10% |
| 2027 | 12.74% | 23.81% |
| 2028 | 17.71% | 39.01% |
12 MongoDB Analysts have issued a net profit forecast 2026. The average MongoDB net profit estimate is $-283m . This is 96.51% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $-195m 35.19% , the lowest is $-386m 168.16% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2025 | $-139m | 30.24% |
|---|---|---|
| 2026 | $-283m | 103.32% |
| 2027 | $-260m | 8.32% |
| 2028 | $-168m | 35.18% |
Net Margin
| 2025 | -6.94% | 41.49% |
|---|---|---|
| 2026 | -12.42% | 79.01% |
| 2027 | -9.77% | 21.34% |
| 2028 | -5.34% | 45.34% |
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
12 Analysts have issued a MongoDB forecast for earnings per share. The average MongoDB EPS is $-3.52 . This is 96.65% lower than earnings per share in the financial year 2025. The highest EPS forecast is $-2.42 35.20% , the lowest is $-4.80 168.16% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2025 | $-1.73 | 30.24% |
|---|---|---|
| 2026 | $-3.52 | 103.47% |
| 2027 | $-3.22 | 8.52% |
| 2028 | $-2.09 | 35.09% |
P/E ratio
| Current | -110.95 | 22.62% |
|---|---|---|
| 2026 | -56.48 | 49.09% |
| 2027 | -61.60 | 9.07% |
| 2028 | -95.03 | 54.27% |
Based on analysts' sales estimates for 2026, the MongoDB stock is valued at an EV/Sales of 5.50 and an P/S ratio of 6.49 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 6.25 | 58.05% |
|---|---|---|
| 2026 | 5.50 | 12.00% |
| 2027 | 4.72 | 14.21% |
| 2028 | 3.98 | 15.73% |
| 2029 | 3.36 | 15.49% |
| 2030 | 2.87 | 14.48% |
P/S ratio
| Current | 7.37 | 52.01% |
|---|---|---|
| 2026 | 6.49 | 11.95% |
| 2027 | 5.57 | 14.21% |
| 2028 | 4.69 | 15.73% |
| 2029 | 3.97 | 15.49% |
| 2030 | 3.39 | 14.48% |
Current MongoDB Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Macquarie |
Neutral
➜
Neutral
|
Unchanged | Mar 07 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Mar 06 2025 |
| B of A Securities |
Buy
➜
Buy
|
Unchanged | Mar 06 2025 |
| Canaccord Genuity |
Buy
➜
Buy
|
Unchanged | Mar 06 2025 |
| Baird |
Outperform
➜
Outperform
|
Unchanged | Mar 06 2025 |
| Goldman Sachs |
Buy
➜
Buy
|
Unchanged | Mar 06 2025 |
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Mar 06 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Macquarie:
Neutral
➜
Neutral
|
Mar 07 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Mar 06 2025 |
|
Unchanged
B of A Securities:
Buy
➜
Buy
|
Mar 06 2025 |
|
Unchanged
Canaccord Genuity:
Buy
➜
Buy
|
Mar 06 2025 |
|
Unchanged
Baird:
Outperform
➜
Outperform
|
Mar 06 2025 |
|
Unchanged
Goldman Sachs:
Buy
➜
Buy
|
Mar 06 2025 |
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Mar 06 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
